Evaluation of Nano‐curcumin effects against Tartrazine‐induced abnormalities in liver and kidney histology and other biochemical parameters

In the current study, 40 albino male rats were investigated to evaluate the impact of Nano‐curcumin (Nano‐CUR) administration against Tartrazine (TZ)‐induced variations in kidney and liver histology and their related functions. The liver function biomarkers are (glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma‐glutamyl transaminase (GGT), alkaline phosphatase (ALP), total bilirubin (T. BiLL)), whereas the kidney biomarkers are (creatinine, uric acid, urea, globulin, total protein (TP)), as well as blood parameters of (serum glucose (sGlu), alpha‐fetoprotein (AFP), protein Kinase‐C (PKC)) and lipid profiles that include (total lipids (TL), triglyceride (TG), total cholesterol (TC), low‐density lipoprotein‐cholesterol (LDL‐C), high‐density L‐C (HDL‐C), and very‐low‐density L‐C (VLDL‐C)). The collected rats were randomly separated into four different groups (G1, G2, G3, and G4) of 10 rats each, where G1 stands for control, G2 for TZ‐ingestion, G3 for Nano‐CUR‐ingestion, and G4 for (TZ + Nano‐CUR mix.) ingestion. TZ‐ingestion significantly (p